Search

Search Constraints

You searched for: Author/Creator Cadranel, Jacques

Search Results

31. First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial. Issue 2 (27th August 2020)

32. Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. (4th September 2018)

33. Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients. Issue 2 (10th August 2017)

35. Immunotherapy: a new standard of care in thoracic malignancies?: A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly. Issue 2 (15th February 2018)

36. Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo). (January 2019)

37. Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis. Issue 6 (4th June 2020)

38. Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. (February 2020)

39. Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study. (September 2022)